"COVID-19: What Pharmacists Need to Know" offers a multi-module CE webinar curriculum program that delivers current, credible information.
The curriculum features webinars on key issues related to the changing landscape of pharmacy practice in light of COVID-19, each with a different expert faculty presenter:
Webinar 1: "COVID-19 Basics and Effect on Pharmacy Practice," Rupal Mansukhani, Pharm.D., FAPhA, CTTS, on-demand webinar available here.
Webinar 2: "Existing and Investigational Pharmacotherapy for COVID-19," Jason C. Gallagher, Pharm.D., FCCP, FIDP, FIDSA, BCPS, on May 31, at 12:00 p.m. EST.
Webinar 3: "COVID-19: Industry's Response and Caring for Patients on the Front Line," Mary Barna Bridgeman, Pharm.D., BCPS, BCGP, on June 7, at 12:00 p.m. EST.
Webinar 4: "Psychosocial Effects and Quality of Life Impact of COVID-19," Mona K. Patel, Pharm.D., FCCM, BCCCP, on June 14, at 12:00 p.m. EST.
Webinar 5: "Update on COVID-19 Clinical Data and Impact on Reimbursement or Patient Access," Kelly E. Pillinger, Pharm.D., BCPS, BCIDP, on June 28, at 12:00 p.m. EST.
Completing these CE webinars will equip pharmacists with the most up-to-date data available on virology, emerging therapies and vaccines and patient management, as well as mental health, financial and quality of life burdens of COVID-19 on patients and health care personnel. Participants who complete all activities in this series will receive a certificate of completion.
Each activity is accredited by the Accreditation Council for Pharmacy Education and is approved for 0.75 contact hour (0.075 CEU).
This resource center is supported by an educational grant from Pfizer Inc.
Pharmacy Times Continuing Education is in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PTCE's print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team.
PTCE is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter
Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15
GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand
Novavax COVID-19 vaccine approved in US
WHO and UNICEF deploy PharmaJet's Tropis ID system in Afghanistan polio campaign
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial